Proteomic identification of secreted proteins as surrogate markers for signal transduction inhibitor activity

British Journal of Cancer

Volumn 96, Issue 2, 2007, Pages 284-289

  McClelland, C M ^a   Gullick, W J ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Epidermal growth factor receptor; Gefitinib; Proteomics; Signal transduction; Surrogate marker

Indexed keywords

GEFITINIB; PROTEIN DISULFIDE ISOMERASE;

ARTICLE; CANCER CELL CULTURE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONCENTRATION (PARAMETERS); DISEASE MARKER; DOWN REGULATION; DRUG ACTIVITY; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; ISOELECTRIC FOCUSING; NEOPLASM PROTEINS; PROTEOMICS; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33846540691     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603544     Document Type: Article

References (39)

1. Albanell J, Rojo F, Averbuch S, Feyereislova A, Mascaro JM, Herbst R, LoRusso P, Rischin D, Sauleda S, Gee J, Nicholson RI, Baselga J (2002) Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition. J Clin Oncol 20: 110-124
2. Baselga J (2003) Skin as a surrogate tissue for pharmacodynamic end points: is it deep enough? Clin Cancer Res 9: 2389-2390
3. Baselga J, Arteaga CL (2005) Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol 23: 2445-2459
4. Benson JD, Chen YN, Cornell-Kennon SA, Dorsch M, Kim S, Leszczyniecka M, Sellers WR, Lengauer C (2006) Validating cancer drug targets. Nature 441: 451-456
5. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
6. Brehmer D, Greff Z, Godl K, Blencke S, Kurtenbach A, Weber M, Muller S, Klebl B, Cotten M, Keri G, Wissing J (2005) Cellular targets of gefitinib. Cancer Res 65: 379-382
7. Chang YS, Wu W, Walsh G, Hong WK, Mao L (2003) Enolase-a is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behaviour. Clin Cancer Res 9: 3641-3644
8. Chen G, Gharib TG, Huang CC, Thomas DG, Shedden KA, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG (2002) Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumours. Clin Cancer Res 8: 2290-2305
9. Ferrari DM, Soling HD (1999) The protein disulphide-isomerase family: Orringer, MB unravelling a string of folds. Biochem J 339: 1-10
10. Freedman RB, Hirst TR, Tuite MF (1994) Protein disulphide isomerase: building bridges in protein folding. Trends Biochem Sci 19: 331-336
11. Frickel E, Frei P, Bouvier M, Stafford WF, Helenius A, Glockshuber R, Ellgaard L (2004) Erp57 is a multifunctional thiol-disulfide oxidoreductase. J Biol Chem 279: 18277-18287
12. Garber K (2006) The second wave in kinase cancer drugs. Nat Biotechnol 24: 127-130
13. Hahn WC, Weinberg RA (2002) Rules for making human tumor cells. N Engl J Med 347: 1593-1603
14. Herbert B, Galvani M, Hamdan M, Olivieri E, MaCarthy J, Pedersen S, Righetti P (2001) Reduction and alkylation of proteins in preparation of two-dimensional map analysis: why when and how? Electrophoresis 10: 2046-2057
15. Jacobs EL, Haskell CM (1991) Clinical use of tumour markers in oncology. Curr Probl Cancer 15: 299-360
16. Jiang X, Fitzgerald M, Grant CM, Hogg PJ (1999) Redox control of exofacial protein thiols/disulfides by protein disulfide isomerase. J Biol Chem 274: 2416-2423
17. Kondo A, Sakaguchi M, Makino E, Namba M, Okada S, Huh N (2002) Localization of S100C immunoreactivity in various human tissues. Acta Med Okayama 56: 31-34
18. Lichtenfels R, Kellner R, Bukur J, Beck J, Brenner W, Ackermann A, Seliger B (2002) Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma. Proteomics 2: 561-570
19. Mahon P, Dupree P (2001) Quantitative and reproducible two-dimensional gel analysis using Phoretix 2D full. Electrophoresis 22: 2075-2085
20. Mair J (1997) Progress in myocardial damage detection: new biochemical markers for clinicans. Crit Rev Clin Lab Sci 34: 1-66
21. Milner CM, Campbell RD (1990) Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 32: 242-251
22. Mosesson Y, Yarden Y (2004) Oncogenic growth factor receptors: implications for signal transduction therapy. Semin Cancer Biol 14: 262-270
23. Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, DePrimo SE, Li JZ, Bello CL, Theuer CP, George DJ, Rini BI (2006) Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 24: 16-24
24. Normanno N, Maiello MR, Mancino M, De Luca A (2004) Small molecule epidermal growth factor receptor tyrosine kinase inhibitors: an overview. J Chemother 16: 36-40
25. Pancholi V (2001) Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 58: 902-920
26. Perkins D, Pappin D, Creasy D, Cottrell J (1999) Probability based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20: 3551-3567
27. Ross JS, Symmans WF, Pusztai L, Hortobagyi GN (2005) Pharmacogenomics and clinical biomarkers in drug discovery and development. Am J Clin Pathol 124(Suppl): S29-S41
28. Sato K, Nakamura T, Mizuguchi M, Miura K, Tada M, Aizawa T, Gomi T, Miyamoto K, Kawano K (2003) Solution structure of epiregulin and the effect of its C-terminal domain for receptor binding affinity. FEBS Lett 553: 232-238
29. Sebolt-Leopold JS, English JM (2006) Mechanisms of drug inhibition of signalling molecules. Nature 441: 457-462
30. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858
31. Shin BK, Wang H, Yim A, Le Naour F, Brichory F, Jang JH, Zhao R, Puravs E, Tra J, Michael CW, Misek DE, Hanash SM (2003) Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem 278: 7607-7616
32. Sullivan D, Huminiecki L, Moore J, Boyle J, Poulsom R, Creamer D, Barker J, Bicknell R (2003) EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor. J Biol Chem 278: 47079-47088
33. Takashima M, Kuramitsu Y, Yokoyama Y, Lizuka N, Toda T, Sakaida I, Okita K, Oka M, Nakamura K (2003) Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 3: 2487-2493
34. Warren CM, Landgraf R (2006) Signaling through ERBB receptors: multiple layers of diversity and control. Cell Signal 18: 923-933
35. Watanabe H, Seino T, Sato Y (2004) Antibodies to triosephosphate isomerase in patients with neuropsychiatric lupus. Biochem Biophys Res Commun 321: 949-953
36. Wehner PS, Nielsen B, Hokland M (2003) Expression levels of hsc70 and hsp60 are developmentally regulated during B-cell maturation and not associated to childhood c-ALL at presentation or relapse. Eur J Haematol 71: 100-108
37. Xiang Y, Nakamura H, Imajoh-Ohmi S, Fukuda H, Nishioka K, Kato T (2004) Proteomic surveillance of autoimmunity in osteoarthritis:identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis Rheum 50: 1511-1521
38. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137
39. Yoshimori T, Semba T, Takemoto H, Akagi S, Yamamato A, Tashiro Y (1990) Protein disulfide-isomerase in rat exocrine pancreatic cells is exported from the endoplasmic reticulum despite possessing the retention signal. J Biol Chem 265: 15984-15990